Patents by Inventor Faye E. Nashold

Faye E. Nashold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL
    Publication number: 20090221538
    Abstract: Prophylactic or therapeutic treatment to inhibit the development or progress of multiple sclerosis symptoms is provided by providing intermittently administered elevated doses of calcitriol, sufficiently infrequently to avoid hypercalcemia. Such methods may include maintaining at least about a normal blood level of vitamin D3 as evidenced by a 25-(OH)D3 level of at least about 50 nmol/L.
    Type: Application
    Filed: February 2, 2009
    Publication date: September 3, 2009
    Inventors: Colleen E. Hayes, Richard Derks, Faye E. Nashold
  • Treating vitamin D responsive diseases
    Patent number: 6989377
    Abstract: The present invention relates to therapeutics for the prevention and treatment of vitamin D responsive diseases in humans, as well as other animals, through the use of biologically active vitamin D compounds in combination with at least one other immunomodulatory compound such as interleukin-10, interleukin-4, or a TNF? inhibitor.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: January 24, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Patent number: 6858595
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: February 22, 2005
    Assignee: Wisconsin Alumni Research Association
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Treating vitamin D responsive diseases
    Publication number: 20030109506
    Abstract: The present invention relates to therapeutics for the prevention and treatment of vitamin D responsive diseases in humans, as well as other animals, through the use of biologically active vitamin D compounds in combination with at least one other immunomodulatory compound such as interleukin-10, interleukin-4, or a TNF&agr; inhibitor.
    Type: Application
    Filed: June 13, 2002
    Publication date: June 12, 2003
    Applicant: Northern Lights Pharmaceuticals, LLC
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Publication number: 20020128241
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 12, 2002
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Patent number: 6358939
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: March 19, 2002
    Assignee: Northern Lights Pharmaceuticals, LLC
    Inventors: Colleen E. Hayes, Faye E. Nashold